Literature DB >> 27911468

Radical Cystectomy and Cutaneous Ureterostomy in 4 Dogs with Trigonal Transitional Cell Carcinoma: Description of Technique and Case Series.

Rafael Ricardo Huppes1, Leandro Z Crivellenti2,3, Andrigo Barboza De Nardi3, Bruno Roque Lima4, Cristiane Alves Cintra2, Jorge Luiz Costa Castro5, Christopher A Adin6.   

Abstract

OBJECTIVE: To describe radical cystectomy followed by cutaneous ureterostomy as a treatment of invasive bladder neoplasia in dogs. STUDY
DESIGN: Retrospective study. ANIMALS: Client-owned dogs with transitional cell carcinoma of the bladder trigone (n=4).
METHODS: Perioperative complications and long-term outcomes of dogs that underwent cutaneous ureterostomy following radical cystectomy and lymphadenectomy for transitional cell carcinoma of the urinary bladder trigone were reviewed. Both ureters were transected and anastomosed to the ventral abdominal skin. Polyvinyl chloride catheters were placed in the ureteral stomas and maintained for 5 days. After catheter removal, dogs were managed with an absorbent diaper over the stomas. Long-term outcome and survival were documented by follow-up visits or phone contact.
RESULTS: Median age at the time of surgery was 10.3 years (range, 8-12). Average procedural time was ∼4.7 hours (range, 3.8-6.1). Minor complications occurred in all dogs, including bleeding and edema of the ureterostomy site during the first 2-3 days after surgery. One dog developed urine scald that resolved with improved stoma care and hygiene. Median survival time after surgery was 278.6 days (range, 47-498). Distant metastases were documented in 2 dogs at 47 days (bone) and 369 days (lung) after surgery.
CONCLUSION: Radical cystectomy with cutaneous ureterostomy is a viable salvage procedure for urinary diversion after cystectomy in dogs with invasive bladder neoplasia. Postoperative management and quality of life were considered acceptable by most owners. Future studies are warranted to evaluate survival time in a larger number of animals.
© 2016 The American College of Veterinary Surgeons.

Entities:  

Mesh:

Year:  2016        PMID: 27911468     DOI: 10.1111/vsu.12583

Source DB:  PubMed          Journal:  Vet Surg        ISSN: 0161-3499            Impact factor:   1.495


  4 in total

1.  Clinical outcomes of dogs with transitional cell carcinoma receiving medical therapy, with and without partial cystectomy.

Authors:  Marcus L Bradbury; Christine M Mullin; Shaban D Gillian; Chick Weisse; Philip J Bergman; Michelle A Morges; Lauren R May; David M Vail; Craig A Clifford
Journal:  Can Vet J       Date:  2021-02       Impact factor: 1.008

2.  Treatment of genitourinary carcinoma in dogs using nonsteroidal anti-inflammatory drugs, mitoxantrone, and radiation therapy: A retrospective study.

Authors:  Benoit Clerc-Renaud; Tracy L Gieger; Susan M LaRue; Michael W Nolan
Journal:  J Vet Intern Med       Date:  2021-02-26       Impact factor: 3.333

Review 3.  Molecular Markers in Urinary Bladder Cancer: Applications for Diagnosis, Prognosis and Therapy.

Authors:  Ana Mafalda Rasteiro; Eva Sá E Lemos; Paula A Oliveira; Rui M Gil da Costa
Journal:  Vet Sci       Date:  2022-02-28

4.  Laparoscopic-assisted cutaneous ureterostomy in a canine patient with prostatic carcinoma.

Authors:  Giovanni Allevi; Carlotta Spediacci; Elena Marchesi; Marco Trovatelli
Journal:  Vet Med Sci       Date:  2021-07-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.